Tr1x, Inc.
Clinical trials sponsored by Tr1x, Inc., explained in plain language.
-
New cell therapy hopes to slow progressive MS
Disease control Recruiting nowThis early-stage trial tests a new drug called TRX319 in 39 adults with progressive multiple sclerosis (MS). The goal is to see if it is safe and to find the best dose. Participants will receive up to three infusions over a year and undergo blood tests, MRI scans, and spinal taps…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New cell therapy TRX103 offers hope for tough Crohn's cases
Disease control Recruiting nowThis study tests a new treatment called TRX103 for people with moderate to severe Crohn's disease that hasn't improved with other treatments. The goal is to see if TRX103 is safe and can help control the disease. About 39 adults aged 18 to 65 will receive different doses of TRX10…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC